GlassScriptPhysician profile
Reena Tahilramani
NPI 1235393737
$9,573.93
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.80 · 2020: $8,901 · 2021: $270 · 2022: $127 · 2023: $54.49 · 2024: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130 · Travel and Lodging: $93.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.84 |
| Travel and Lodging | $93.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,938.91 | 2019-2024 | |
| Stryker Corporation | $105.98 | 2020 | |
| Abbvie INC. | $45.73 | 2024 | |
| Axonics, INC. | $45.63 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.87 | 2021-2024 | Glassia |
| Thd America, INC. | $37.53 | 2021-2024 | |
| Smith+Nephew, INC. | $36.02 | 2022-2023 | Pico |
| Sunovion Pharmaceuticals INC. | $34.76 | 2020-2021 | |
| Medela LLC | $34.57 | 2022 | |
| Kerecis Limited | $30.23 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $28.12 | 2022 | |
| Braintree Laboratories, INC. | $24.59 | 2020 | |
| Covidien LP | $22.90 | 2020 | |
| Convatec INC. | $20.36 | 2021 | |
| Intra-Sana Laboratories | $19.85 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.73 | 2021 | |
| Standard Bariatrics, INC. | $16.55 | 2022 | |
| Novo Nordisk INC | $15.87 | 2022 | |
| Heron Therapeutics, INC. | $15.67 | 2021 | |
| Acell, INC. | $14.86 | 2020 | |
| La Jolla Pharmaceutical Company | $14.13 | 2021 | |
| Trevena, INC. | $14.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reena Tahilramani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.